Valuation: Genpharmasec Limited

Market Cap 609M 6.48M 5.86M 5.41M 4.9M 9.24M 9.51M 64.92M 25.8M 326M 24.32M 23.8M 1.04B P/E 2025
94.5x
P/E 2026 26.9x
Enterprise Value 858M 9.12M 8.25M 7.62M 6.89M 13.01M 13.4M 91.42M 36.33M 459M 34.25M 33.52M 1.46B EV / Sales 2025
2.96x
EV / Sales 2026 0.49x
Free-Float
54.91%
Yield 2025 *
-
Yield 2026 -
1 day-0.91%
1 week-0.91%
Current month+10.10%
1 month+9.00%
3 months+6.86%
6 months-4.39%
Current year-16.79%
1 week 0.91
Extreme 0.91
1.16
1 month 0.91
Extreme 0.91
1.17
Current year 0.75
Extreme 0.75
1.45
1 year 0.75
Extreme 0.75
1.62
3 years 0.75
Extreme 0.75
8.71
5 years 0.75
Extreme 0.75
11.08
10 years 0.75
Extreme 0.75
18
Manager TitleAgeSince
Director of Finance/CFO 39 01/11/2022
Compliance Officer - 27/03/2024
Director TitleAgeSince
Director/Board Member 58 02/01/2019
Director/Board Member 58 02/01/2019
Director/Board Member - 01/11/2022
Change 5-day change 1-year change 3-year change Capi.($)
-0.91%-0.91%-29.68%-75.11% 6.48M
-1.87%-5.59%-16.74%+14.13% 186B
-0.61%-3.67%+5.41%+42.88% 124B
-2.01%-6.77%-14.96%+14.17% 119B
-1.45%-6.28%-43.90%+2.86% 91.43B
-0.14%+2.86%-3.86%+76.84% 66.67B
+0.55%+1.01%+12.28%-8.07% 58.76B
-0.65%+4.07%-2.18%+62.81% 54.99B
-0.68%+6.83%-1.64%+55.26% 49.93B
-5.17%+0.55% - - 35.13B
Average -1.29%-2.04%-10.59%+20.64% 79B
Weighted average by Cap. -1.30%-3.37%-10.63%+27.64%

Financials

2025 2026
Net sales 337M 3.59M 3.24M 2.99M 2.71M 5.11M 5.27M 35.94M 14.28M 180M 13.46M 13.18M 574M 1.4B 14.89M 13.46M 12.43M 11.25M 21.22M 21.86M 149M 59.27M 748M 55.87M 54.68M 2.38B
Net income 12.31M 131K 118K 109K 98.95K 187K 192K 1.31M 521K 6.58M 492K 481K 20.95M 16.04M 171K 154K 142K 129K 243K 251K 1.71M 679K 8.57M 640K 627K 27.29M
Net Debt -9.4M -100K -90.45K -83.49K -75.57K -143K -147K -1M -398K -5.03M -375K -367K -16M 249M 2.65M 2.39M 2.21M 2M 3.77M 3.89M 26.51M 10.53M 133M 9.93M 9.72M 423M
Projected Income Statement - Annual - Genpharmasec Limited
Logo Genpharmasec Limited
Genpharmasec Limited is an India-based company, which is engaged in the distribution of diagnostic pharma equipment and trading of securities. The Company’s segments include Pharmaceuticals, Trading in Securities, and Laboratory Testing. The Trading in Securities segment invests in the secondary securities market. The Company holds rights to the distribution of equipment, such as i-STAT Analyzers and its Cartridges, manufactured by Abbott Point of Care, USA, all over India. The i-STAT Analyzer is a blood analyzer used in Intensive Care Units (ICUs) of hospitals and provides test results in approximately 10 minutes. The Company’s wholly owned subsidiary includes M/s. Clinigenome India Private Limited.
Employees
13
Date Price Change Volume
13/11/26 INR 1.090 -0.91% 211,131
12/11/26 INR 1.100 -1.79% 319,332
11/11/26 INR 1.120 0.00% 281,976
09/11/26 INR 1.120 +0.90% 293,798
08/11/26 INR 1.110 +0.91% 755,288
  1. Stock Market
  2. Stocks
  3. ADIRASA Stock